CONTRATTO PER LA CONDUZIONE DELLA SPERIMENTAZIONE CLINICA SU MEDICINALIClinical Trial Agreement • August 10th, 2023
Contract Type FiledAugust 10th, 2023multi-centre, prospective, randomized, standard-of-care plus placebo-controlled, patient and central evaluator blinded, parallel arm, clinical study to evaluate safety, tolerability and efficacy of the recommended phase-2 dose of AUP1602-C in two dosing frequencies as a topical treatment for non- healing neuro-ischemic diabetic foot ulcers”
CONTRATTO PER LA CONDUZIONE DELLA SPERIMENTAZIONE CLINICA SU MEDICINALI AGREEMENT FOR THE CONDUCT OF THE CLINICAL TRIAL ON MEDICINAL PRODUCTSClinical Trial Agreement • May 12th, 2023
Contract Type FiledMay 12th, 2023Fondazione IRCCS Istituto Neurologico Carlo Besta (d’ora innanzi denominata “Ente”), con sede legale in Milano C.F. 01668320151 e P.IVA n. 04376340156 nella persona del Direttore Generale Dott. Angelo Cordone, che sottoscrive il presente atto in forza di delega del potere di firma conferita con Deliberazione del C.d.A. n. V/34 del 16 Aprile 2021, domiciliato per la carica presso il citato ente Fondazione IRCCS Istituto Neurologico Carlo Besta (hereinafter referred to as “Institution”), with registered office at Milano, Tax Code 01668320151 and VAT no. 04376340156 in the person of the General Director Angelo Cordone, who signs this act pursuant to the delegation of the power of signature conferred by Resolution of the Board of Directors n. V/34 of 16 April 2021, domiciled for the office at the aforementioned Institution,